BugSpeaks microbiome-based personalized nutrition improves hyperglycaemia and hypertension parameters and reduces inflammation - A prospective, open label, controlled, randomized, comparative, proof of concept study
Recent studies suggest that gut microbiota composition, abundance and diversity can influence many chronic diseases such as type 2 diabetes. Modulating gut microbiota through targeted nutrition can provide beneficial effects leading to the concept of personalized nutrition for health improvement. In this prospective clinical trial we evaluated the impact of a microbiome-based targeted personalized diet on hyperglycaemic and hyperlipidaemic individuals.